Bassam Damaj, President & CEO, 10% Owner at INNOVUS PHARMACEUTICALS, INC. (INNV), bought 416,841 shares at $0.32 ($133K) on 2013-06-12, disclosed to the SEC on 2013-06-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.32 | 129,393 | $41K | 31.0% |
| 2 | $0.32 | 287,448 | $92K | 69.0% |
| Total | $0.32 avg | 416,841 | $133K | 100% |
| Filing → |
| APRI | BUY | 2012-08-21 | $4K | — | Filing → |